About
About GDMT.ca
GDMT.ca was created to help close the evidence-to-practice gap in cardiovascular, kidney, and diabetes care.
Pharmacist-led implementation support
The platform supports pharmacist-led identification and documentation of guideline-directed therapy opportunities using structured clinical data, deterministic clinical logic, and responsible AI-assisted documentation.
Rather than positioning AI as a decision-maker, GDMT.ca is designed to strengthen pharmacist workflow by assembling structured information, applying deterministic checks, and supporting more consistent clinical communication.
Founder
Mark Brady
Mark Brady is a Canadian clinical pharmacist specializing in cardiovascular disease, diabetes, chronic kidney disease, and implementation of guideline-directed medical therapy.
His work focuses on applying trustworthy AI, pharmacist expertise, and implementation science to improve real-world uptake of evidence-based therapy.